Macro News - The National Health Commission and 13 other ministries jointly released a document to correct irregularities in the pharmaceutical procurement and medical services sectors, focusing on key areas such as drug procurement, high-value medical consumables, and project bidding [1] - The World Bank's latest report indicates that China's GDP is expected to grow by 5.4% year-on-year in Q1 2025, driven by policy support and a rebound in housing sales in major cities [5] - The People's Bank of China reported that the social financing scale reached 426.16 trillion yuan by the end of May 2025, with a year-on-year growth of 8.7% [5][7] - In May, China's high-tech industry sales revenue grew by 15% year-on-year, indicating a sustained growth trend [6] Company News - AstraZeneca announced a strategic research collaboration with CSPC Pharmaceutical Group, focusing on AI-driven drug research, with CSPC receiving an upfront payment of $110 million and potential milestone payments totaling up to $16.2 billion [9] - Tencent has no plans to acquire Nexon, as confirmed by sources close to the company [8] - The AI glasses developed in collaboration with ByteDance by Lao Feng Xiang are still undergoing testing and are expected to launch after obtaining sales permits [8]